MedPath

Medical University of South Carolina

Medical University of South Carolina logo
🇺🇸United States
Ownership
Private
Established
1955-01-01
Employees
10K
Market Cap
-
Website
https://www.muschealth.com

Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells

Phase 1
Terminated
Conditions
Melanoma
Interventions
Procedure: leukapheresis
First Posted Date
2013-02-04
Last Posted Date
2015-10-02
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
1
Registration Number
NCT01783431
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Comparison of an Antibiotic Impregnated PICC Catheter Versus a Regular PICC Catheter in a Tertiary Care Setting

Phase 2
Withdrawn
Conditions
Peripherally Inserted Central Catheters
Interventions
Device: PICC (Cook, Bard)
First Posted Date
2013-01-10
Last Posted Date
2018-06-18
Lead Sponsor
Medical University of South Carolina
Registration Number
NCT01765738
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

LARGE Aneurysm Randomized Trial: Flow Diversion Versus Traditional Endovascular Coiling Therapy

Phase 4
Terminated
Conditions
Intracranial Aneurysm
Interventions
Procedure: Flow Diversion
Procedure: Coiling
First Posted Date
2013-01-07
Last Posted Date
2018-02-13
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
23
Registration Number
NCT01762137
Locations
🇺🇸

MUSC, Charleston, South Carolina, United States

Ketamine in Chronic Kid's (KiCK) Pain

Phase 2
Terminated
Conditions
Chronic Pain
Interventions
Drug: Placebo
First Posted Date
2012-12-24
Last Posted Date
2017-01-23
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
7
Registration Number
NCT01755169
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD

Not Applicable
Completed
Conditions
PTSD
Alcohol Use Disorders
Substance Use Disorders
Interventions
Behavioral: Treatment as Usual
Behavioral: Risk Reduction through Family Therapy
First Posted Date
2012-12-17
Last Posted Date
2018-08-03
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
135
Registration Number
NCT01751035
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Social Determinants of Health in Diabetes Outcomes

Completed
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2012-12-13
Last Posted Date
2018-05-08
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
650
Registration Number
NCT01749345
Locations
🇺🇸

Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States

🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)

Phase 2
Completed
Conditions
Cognitive Impairment
Parkinson's Disease
Interventions
Drug: Placebo
First Posted Date
2012-11-30
Last Posted Date
2018-08-23
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
30
Registration Number
NCT01738191
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Transcranial Magnetic Stimulation Effects on Nicotine Craving

Not Applicable
Completed
Conditions
Nicotine Dependence
Interventions
Device: Transcranial Magnetic Stimulation (Neuronetics)
Device: Sham Transcranial Magnetic Stimulation
First Posted Date
2012-09-21
Last Posted Date
2020-04-01
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
19
Registration Number
NCT01690130
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving

Not Applicable
Completed
Conditions
Methamphetamine Dependence
Interventions
Device: Transcranial Magnetic Stimulation
Device: Sham Transcranial Magnetic Stimulation
First Posted Date
2012-09-14
Last Posted Date
2020-04-01
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
18
Registration Number
NCT01685463
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma

Phase 2
Terminated
Conditions
Adenocarcinoma of Head of Pancreas
Interventions
Drug: Neo-adjuvant Chemotherapy
Radiation: Chemoradiation
Procedure: Surgical Resection
First Posted Date
2012-09-03
Last Posted Date
2016-01-15
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
3
Registration Number
NCT01677988
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath